Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIMP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PIWIL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC34 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
KALRN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HAMP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKAP7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGLJ3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
N4BP2L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TP53AIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC146513 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CARD14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMOD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on